DCP1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.709800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.999000E-01
Normal-vs-Stage2
1.688190E-01
Normal-vs-Stage3
8.978300E-02
Normal-vs-Stage4
5.458600E-01
Stage1-vs-Stage2
5.098800E-01
Stage1-vs-Stage3
4.104200E-02
Stage1-vs-Stage4
1.687040E-01
Stage2-vs-Stage3
2.040400E-04
Stage2-vs-Stage4
2.226500E-02
Stage3-vs-Stage4
1.961800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.667350E-01
Normal-vs-AfricanAmerican
7.352600E-01
Normal-vs-Asian
7.206100E-02
Caucasian-vs-AfricanAmerican
2.940400E-01
Caucasian-vs-Asian
2.332400E-01
AfricanAmerican-vs-Asian
1.941610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.018800E-01
Normal-vs-Female
1.483630E-01
Male-vs-Female
9.347400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.625000E-01
Normal-vs-Age(41-60Yrs)
4.626000E-01
Normal-vs-Age(61-80Yrs)
9.152200E-02
Normal-vs-Age(81-100Yrs)
5.427600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.002400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.178200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.613020E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.478500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.299600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.369000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.577600E-02
Normal-vs-Daily Drinker
5.796000E-02
Normal-vs-Weekly Drinker
1.022620E-01
Normal-vs-Occasional Drinker
3.500000E-01
Normal-vs-Social Drinker
3.410800E-01
Non Drinker-vs-Daily Drinker
7.874200E-01
Non Drinker-vs-Weekly Drinker
6.833200E-01
Non Drinker-vs-Occasional Drinker
1.068370E-01
Non Drinker-vs-Social Drinker
1.937370E-01
Daily Drinker-vs-Weekly Drinker
8.617800E-01
Daily Drinker-vs-Occasional Drinker
1.886160E-01
Daily Drinker-vs-Social Drinker
3.008000E-01
Weekly Drinker-vs-Occasional Drinker
3.282000E-01
Weekly Drinker-vs-Social Drinker
4.537000E-01
Occasional Drinker-vs-Social Drinker
8.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.417000E-01
Normal-vs-Grade 2
3.032100E-02
Normal-vs-Grade 3
2.808000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.852400E-01
Grade 1-vs-Grade 3
4.673400E-01
Grade 1-vs-Grade 4
1.417000E-01
Grade 2-vs-Grade 3
9.511400E-01
Grade 2-vs-Grade 4
3.032100E-02
Grade 3-vs-Grade 4
2.808000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.822200E-02
Normal-vs-NonDiabetic
1.184370E-01
Diabetic-vs-NonDiabetic
5.944800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.066010E-01
Normal-vs-NoPancreatitis
1.245560E-01
Pancreatitis-vs-NoPancreatitis
8.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.013000E-01
Normal-vs-N1
1.753970E-01
N0-vs-N1
7.168600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.645600E-01
Normal-vs-TP53-NonMutant
2.990000E-01
TP53-Mutant-vs-TP53-NonMutant
9.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
